Skip to main content
Top
Published in: Molecular Cancer 1/2010

Open Access 01-12-2010 | Research

The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition

Authors: David S. Yee, Yaxiong Tang, Xuesen Li, Zhongbo Liu, Yi Guo, Samia Ghaffar, Peter McQueen, Dash Atreya, Jun Xie, Anne R. Simoneau, Bang H. Hoang, Xiaolin Zi

Published in: Molecular Cancer | Issue 1/2010

Login to get access

Abstract

Background

Aberrations in the Wnt pathway have been reported to be involved in the metastasis of prostate cancer (PCa) to bone. We investigated the effect and underlying mechanism of a naturally-occurring Wnt inhibitor, WIF1, on the growth and cellular invasiveness of a bone metastatic PCa cell line, PC3.

Results

The WIF1 gene promoter was hypermethylated and its expression down-regulated in the majority (7 of 8) of PCa cell lines. Restoration of WIF1 expression in PC-3 cells resulted in a decreased cell motility and invasiveness via up-regulation of epithelial markers (E-cadherin, Keratin-8 and-18), down-regulation of mesenchymal markers (N-cadherin, Fibronectin and Vimentin) and decreased activity of MMP-2 and -9. PC3 cells transfected with WIF1 consistently demonstrated reduced expression of Epithelial-to-Mesenchymal Transition (EMT) transcription factors, Slug and Twist, and a change in morphology from mesenchymal to epithelial. Moreover, WIF1 expression significantly reduced tumor growth by approximately 63% in a xenograft mouse model. This was accompanied by an increased expression of E-cadherin and Keratin-18 and a decreased expression of vimentin in tumor tissues.

Conclusion

These data suggest that WIF1 regulates tumor invasion through EMT process and thus, may play an important role in controlling metastatic disease in PCa patients. Blocking Wnt signaling in PCa by WIF1 may represent a novel strategy in the future to reduce metastatic disease burden in PCa patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59: 225-49. 10.3322/caac.20006CrossRefPubMed Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59: 225-49. 10.3322/caac.20006CrossRefPubMed
2.
go back to reference Feldman BJ, Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001, 1: 34-45. 10.1038/35094009CrossRefPubMed Feldman BJ, Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001, 1: 34-45. 10.1038/35094009CrossRefPubMed
3.
go back to reference Emami KH, Corey E: When prostate cancer meets bone: control by wnts. Cancer Lett. 2007, 253: 170-9. 10.1016/j.canlet.2006.12.040CrossRefPubMed Emami KH, Corey E: When prostate cancer meets bone: control by wnts. Cancer Lett. 2007, 253: 170-9. 10.1016/j.canlet.2006.12.040CrossRefPubMed
4.
go back to reference Paul S, Dey A: Wnt signaling and cancer development: therapeutic implication. Neoplasma. 2008, 55: 165-76.PubMed Paul S, Dey A: Wnt signaling and cancer development: therapeutic implication. Neoplasma. 2008, 55: 165-76.PubMed
6.
go back to reference Hoang B, Moos M, Vukicevic S, Luyten FP: Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem. 1996, 271: 26131-7. 10.1074/jbc.271.42.26131CrossRefPubMed Hoang B, Moos M, Vukicevic S, Luyten FP: Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem. 1996, 271: 26131-7. 10.1074/jbc.271.42.26131CrossRefPubMed
7.
go back to reference Leyns L, Bouwmeester T, Kim SH, Piccolo S, De Robertis EM: Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell. 1997, 88: 747-56. 10.1016/S0092-8674(00)81921-2PubMedCentralCrossRefPubMed Leyns L, Bouwmeester T, Kim SH, Piccolo S, De Robertis EM: Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell. 1997, 88: 747-56. 10.1016/S0092-8674(00)81921-2PubMedCentralCrossRefPubMed
8.
go back to reference Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998, 391: 357-62. 10.1038/34848CrossRefPubMed Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998, 391: 357-62. 10.1038/34848CrossRefPubMed
9.
go back to reference Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA. 1997, 94: 2859-63. 10.1073/pnas.94.7.2859PubMedCentralCrossRefPubMed Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA. 1997, 94: 2859-63. 10.1073/pnas.94.7.2859PubMedCentralCrossRefPubMed
10.
go back to reference Hajra KM, Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer. 2002, 34: 255-68. 10.1002/gcc.10083CrossRefPubMed Hajra KM, Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer. 2002, 34: 255-68. 10.1002/gcc.10083CrossRefPubMed
11.
go back to reference Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004, 36: 417-22. 10.1038/ng1330CrossRefPubMed Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004, 36: 417-22. 10.1038/ng1330CrossRefPubMed
12.
go back to reference Bafico A, Liu G, Goldin L, Harris V, Aaronson SA: An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004, 6: 497-506. 10.1016/j.ccr.2004.09.032CrossRefPubMed Bafico A, Liu G, Goldin L, Harris V, Aaronson SA: An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004, 6: 497-506. 10.1016/j.ccr.2004.09.032CrossRefPubMed
13.
go back to reference Hall CL, Keller ET: The role of Wnts in bone metastases. Cancer Metastasis Rev. 2006, 25: 551-8. 10.1007/s10555-006-9022-2CrossRefPubMed Hall CL, Keller ET: The role of Wnts in bone metastases. Cancer Metastasis Rev. 2006, 25: 551-8. 10.1007/s10555-006-9022-2CrossRefPubMed
14.
go back to reference Uysal-Onganer P, Kawano Y, Caro M, Walker MM, Diez S, Darrington RS, Waxman J, Kypta RM: Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer. 2010, 9: 55- 10.1186/1476-4598-9-55PubMedCentralCrossRefPubMed Uysal-Onganer P, Kawano Y, Caro M, Walker MM, Diez S, Darrington RS, Waxman J, Kypta RM: Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer. 2010, 9: 55- 10.1186/1476-4598-9-55PubMedCentralCrossRefPubMed
15.
go back to reference Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA: Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene. 2008, 27: 7118-30. 10.1038/onc.2008.293PubMedCentralCrossRefPubMed Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA: Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene. 2008, 27: 7118-30. 10.1038/onc.2008.293PubMedCentralCrossRefPubMed
16.
go back to reference Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A: Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene. 2010, 29: 2036-46. 10.1038/onc.2009.496CrossRefPubMed Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A: Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene. 2010, 29: 2036-46. 10.1038/onc.2009.496CrossRefPubMed
17.
go back to reference Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM: Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. Biochem Biophys Res Commun. 2006, 341: 635-40. 10.1016/j.bbrc.2005.12.220CrossRefPubMed Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM: Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. Biochem Biophys Res Commun. 2006, 341: 635-40. 10.1016/j.bbrc.2005.12.220CrossRefPubMed
18.
go back to reference Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 2004, 64: 4717-20. 10.1158/0008-5472.CAN-04-1389CrossRefPubMed Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 2004, 64: 4717-20. 10.1158/0008-5472.CAN-04-1389CrossRefPubMed
19.
go back to reference Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM: Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun. 2006, 342: 1228-32. 10.1016/j.bbrc.2006.02.084CrossRefPubMed Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM: Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun. 2006, 342: 1228-32. 10.1016/j.bbrc.2006.02.084CrossRefPubMed
20.
go back to reference Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD: Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 2006, 27: 1341-8. 10.1093/carcin/bgi379CrossRefPubMed Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD: Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 2006, 27: 1341-8. 10.1093/carcin/bgi379CrossRefPubMed
21.
go back to reference Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006, 12: 383-91. 10.1158/1078-0432.CCR-05-1344CrossRefPubMed Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006, 12: 383-91. 10.1158/1078-0432.CCR-05-1344CrossRefPubMed
22.
go back to reference Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R: Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 2009, 69: 8603-10. 10.1158/0008-5472.CAN-09-2534CrossRefPubMed Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R: Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 2009, 69: 8603-10. 10.1158/0008-5472.CAN-09-2534CrossRefPubMed
23.
go back to reference Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM: Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest. 2009, 119: 837-51. 10.1172/JCI37175PubMedCentralCrossRefPubMed Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM: Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest. 2009, 119: 837-51. 10.1172/JCI37175PubMedCentralCrossRefPubMed
24.
go back to reference Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther. 2010, 9: 731-41. 10.1158/1535-7163.MCT-09-0147PubMedCentralCrossRefPubMed Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther. 2010, 9: 731-41. 10.1158/1535-7163.MCT-09-0147PubMedCentralCrossRefPubMed
25.
go back to reference Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T: Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2¡ä-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006, 97: 64-71. 10.1111/j.1349-7006.2006.00136.xCrossRefPubMed Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T: Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2¡ä-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006, 97: 64-71. 10.1111/j.1349-7006.2006.00136.xCrossRefPubMed
26.
go back to reference Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A, Pilarsky C: WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003, 201: 204-12. 10.1002/path.1449CrossRefPubMed Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, Knuechel R, Rosenthal A, Pilarsky C: WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003, 201: 204-12. 10.1002/path.1449CrossRefPubMed
27.
go back to reference Ohigashi T, Mizuno R, Nakashima J, Marumo K, Murai M: Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells. Prostate. 2005, 62: 61-8. 10.1002/pros.20117CrossRefPubMed Ohigashi T, Mizuno R, Nakashima J, Marumo K, Murai M: Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells. Prostate. 2005, 62: 61-8. 10.1002/pros.20117CrossRefPubMed
28.
go back to reference Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, Parmigiani G, Berman DM: Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008, 27: 7180-91. 10.1038/onc.2008.327PubMedCentralCrossRefPubMed Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, Parmigiani G, Berman DM: Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008, 27: 7180-91. 10.1038/onc.2008.327PubMedCentralCrossRefPubMed
29.
go back to reference Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Ishii K, Hayward SW, Matusik RJ, Bhowmick NA: Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation. 2009, 77: 95-102. 10.1016/j.diff.2008.09.012PubMedCentralCrossRefPubMed Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Ishii K, Hayward SW, Matusik RJ, Bhowmick NA: Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation. 2009, 77: 95-102. 10.1016/j.diff.2008.09.012PubMedCentralCrossRefPubMed
30.
go back to reference Surmann-Schmitt C, Widmann N, Dietz U, Saeger B, Eitzinger N, Nakamura Y, Rattel M, Latham R, Hartmann C, von der Mark H, Schett G, von der Mark K, Stock M: Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci. 2009, 122: 3627-37. 10.1242/jcs.048926CrossRefPubMed Surmann-Schmitt C, Widmann N, Dietz U, Saeger B, Eitzinger N, Nakamura Y, Rattel M, Latham R, Hartmann C, von der Mark H, Schett G, von der Mark K, Stock M: Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci. 2009, 122: 3627-37. 10.1242/jcs.048926CrossRefPubMed
31.
go back to reference Cho SW, Yang JY, Sun HJ, Jung JY, Her SJ, Cho HY, Choi HJ, Kim SW, Kim SY, Shin CS: Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone. 2009, 44: 1069-77. 10.1016/j.bone.2009.02.012CrossRefPubMed Cho SW, Yang JY, Sun HJ, Jung JY, Her SJ, Cho HY, Choi HJ, Kim SW, Kim SY, Shin CS: Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone. 2009, 44: 1069-77. 10.1016/j.bone.2009.02.012CrossRefPubMed
32.
go back to reference Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH: Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005, 65: 9762-70. 10.1158/0008-5472.CAN-05-0103CrossRefPubMed Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH: Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005, 65: 9762-70. 10.1158/0008-5472.CAN-05-0103CrossRefPubMed
33.
go back to reference Zi X, Simoneau AR: Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005, 65: 3479-86. 10.1158/0008-5472.CAN-05-0103CrossRefPubMed Zi X, Simoneau AR: Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005, 65: 3479-86. 10.1158/0008-5472.CAN-05-0103CrossRefPubMed
34.
go back to reference Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D: Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer. 2010, 116: 1406-18. 10.1002/cncr.24896CrossRefPubMed Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D: Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer. 2010, 116: 1406-18. 10.1002/cncr.24896CrossRefPubMed
35.
go back to reference Kang Y, Massague J: Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004, 118: 277-9. 10.1016/j.cell.2004.07.011CrossRefPubMed Kang Y, Massague J: Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004, 118: 277-9. 10.1016/j.cell.2004.07.011CrossRefPubMed
36.
go back to reference Vallin J, Thuret R, Giacomello E: Cloning and characterization of three Xenopus Slug promoters reveal direct regulation by Lef/β-catenin signaling. J Biol Chem. 2001, 276: 30350-8. 10.1074/jbc.M103167200CrossRefPubMed Vallin J, Thuret R, Giacomello E: Cloning and characterization of three Xenopus Slug promoters reveal direct regulation by Lef/β-catenin signaling. J Biol Chem. 2001, 276: 30350-8. 10.1074/jbc.M103167200CrossRefPubMed
37.
go back to reference Howe LR, Watanabe O, Leonard J, Brown AM: Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 2003, 63: 1906-13.PubMed Howe LR, Watanabe O, Leonard J, Brown AM: Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 2003, 63: 1906-13.PubMed
38.
go back to reference Luo J, Lubaroff DM, Hendrix MJ: Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 1999, 59: 3552-6.PubMed Luo J, Lubaroff DM, Hendrix MJ: Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 1999, 59: 3552-6.PubMed
39.
go back to reference Marchenko GN, Marchenko ND, Leng J, Strongin AY: Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J. 2002, 363: 253-62. 10.1042/0264-6021:3630253PubMedCentralCrossRefPubMed Marchenko GN, Marchenko ND, Leng J, Strongin AY: Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J. 2002, 363: 253-62. 10.1042/0264-6021:3630253PubMedCentralCrossRefPubMed
40.
go back to reference Wu B, Crampton SP, Hughes CC: Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity. 2007, 26: 227-39. 10.1016/j.immuni.2006.12.007PubMedCentralCrossRefPubMed Wu B, Crampton SP, Hughes CC: Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity. 2007, 26: 227-39. 10.1016/j.immuni.2006.12.007PubMedCentralCrossRefPubMed
41.
go back to reference Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT: Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA. 2010, 107: 2485-90. 10.1073/pnas.0908133107PubMedCentralCrossRefPubMed Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT: Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA. 2010, 107: 2485-90. 10.1073/pnas.0908133107PubMedCentralCrossRefPubMed
42.
go back to reference Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM: Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell. 2007, 12: 559-71. 10.1016/j.ccr.2007.11.004CrossRefPubMed Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM: Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell. 2007, 12: 559-71. 10.1016/j.ccr.2007.11.004CrossRefPubMed
43.
go back to reference Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, Peachey NS, Nathans J: Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009, 139: 285-98. 10.1016/j.cell.2009.07.047PubMedCentralCrossRefPubMed Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, Peachey NS, Nathans J: Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009, 139: 285-98. 10.1016/j.cell.2009.07.047PubMedCentralCrossRefPubMed
44.
go back to reference Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C: Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 2009, 69: 6951-9. 10.1158/0008-5472.CAN-09-0541CrossRefPubMed Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C: Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 2009, 69: 6951-9. 10.1158/0008-5472.CAN-09-0541CrossRefPubMed
45.
go back to reference Franco CA, Liebner S, Gerhardt H: Vascular morphogenesis: a Wnt for every vessel?. Curr Opin Genet Dev. 2009, 19: 476-83. 10.1016/j.gde.2009.09.004CrossRefPubMed Franco CA, Liebner S, Gerhardt H: Vascular morphogenesis: a Wnt for every vessel?. Curr Opin Genet Dev. 2009, 19: 476-83. 10.1016/j.gde.2009.09.004CrossRefPubMed
Metadata
Title
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
Authors
David S. Yee
Yaxiong Tang
Xuesen Li
Zhongbo Liu
Yi Guo
Samia Ghaffar
Peter McQueen
Dash Atreya
Jun Xie
Anne R. Simoneau
Bang H. Hoang
Xiaolin Zi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-9-162

Other articles of this Issue 1/2010

Molecular Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine